Skip to content
Medical Health Aged Care

ANMF condemns fatal shooting of US intensive care nurse

The Australian Nursing and Midwifery Federation (ANMF) < 1 mins read

The Australian Nursing and Midwifery Federation (ANMF) has expressed its deep shock and sorrow at the fatal shooting of intensive care nurse Alex Pretti, during an incident involving ICE agents in Minneapolis.

The ANMF stands with our colleagues across borders in condemning the shooting of Mr Pretti and has called for accountability, transparency and justice in ensuring that his tragic death is properly and independently investigated by US authorities.

Nurses around the world dedicate their lives to caring for others in their communities.

The violent death of a registered nurse is an intolerable breach of the fundamental respect and dignity owed to health professionals who serve the community each and every day.

An attack on one nurse is an attack on the global nursing community.

It’s why the ANMF, on behalf of its members across Australia, denounces this abhorrent act of lethal force which took Mr Pretti’s life.

His death is deeply disturbing to us all.

As the International Council of Nurses (ICN) has repeatedly emphasised, no nurse should ever fear for their life because of their profession, their identity, or the circumstances in which they live and work.

 

We must ensure that no nurse’s life is ever again cut short in such violent circumstances in the future.

 


About us:

The ANMF, with over 345,000 members, is the industrial and professional voice for nurses, midwives and carers in Australia.

ANMF media release authorised by Annie Butler, ANMF Federal Secretary. 1/365 Queen St, Melbourne. 

 

More from this category

  • Finance Investment, Medical Health Aged Care
  • 27/01/2026
  • 10:13
Jane Morgan Management

Nexsen secures $500,000 Federal grant to expand rapid GBS diagnostics into neonatal care

27 January 2026 – Melbourne, Australia | Nexsen Limited (ASX:NXN) has secured a $500,000 non-dilutive Federal Government grant to expand its rapid point-of-care diagnostic platform into neonatal testing, significantly broadening the commercial and clinical scope of its Group B Streptococcus (GBS) program for a materially larger opportunity for testing. The funding has been awarded to RMIT University under the Commonwealth’s Australia’s Economic Accelerator (AEA) Ignite program, with Nexsen appointed as the industry commercialisation partner. The project, titled “Transforming Neonatal Care with a Rapid Diagnostic for Group B Streptococcus (GBS)”, has a total value exceeding $1 million. The initiative will support…

  • Contains:
  • Medical Health Aged Care
  • 27/01/2026
  • 09:00
VADANZ (Voluntary Assisted Dying Australia & NZ)

Urgent Reform Needed to Sustain Voluntary Assisted Dying Services

Key Facts: The 2025 VADANZ Remuneration Survey of Voluntary Assisted Dying (VAD) practitioners has revealed almost two‑thirds (63%) reported their state’s remuneration arrangements were…

  • Contains:
  • Medical Health Aged Care
  • 26/01/2026
  • 18:11
Samsung Epis Holdings

Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results

In its first financial results announcement after the spin-off, Samsung Bioepis recorded FY2025 revenue of KRW 1.672 trillion, highest annual revenue in its 14-year…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.